Omecamtiv Mecarbil

未知生产厂商

Omecamtiv Mecarbil has been used in trials studying the treatment and basic science of Heart Failure, Echocardiogram, Pharmacokinetics, Chronic Heart Failure, and History of Chronic Heart Failure, among others.

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

技术标识符

化学式: C₂₀H₂₄FN₅O₃
CAS 编号: 873697-71-3
UNII ID: 2M19539ERK

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

SALT OF OMECAMTIV MECARBIL AND PROCESS FOR PREPARING SALT
EP 2970123 A1申请人: AMGEN INC优先权: 2013
CN
EP
US
WO
38 件公开
SYNTHESIS OF OMECAMTIV MECARBIL
- EP 3925950 C0
  申请人: AMGEN INC优先权: 2017
  CN
  EP
  US
  WO
  12 件公开
- EP 4305018 A2
  申请人: AMGEN INC优先权: 2021
  CN
  EP
  US
  WO
  5 件公开
SALTS AND CRYSTAL FORMS OF OMECAMTIV MECARBIL
EP 3837009 A1申请人: AMGEN INC优先权: 2018
EP
US
WO
9 件公开
METHODS OF TREATING HEART FAILURE BY ADMINISTERING OMECAMTIV MECARBIL
EP 4706638 A3申请人: AMGEN INC优先权: 2020
EP
US
WO
6 件公开
HETEROCYCLIC COMPOUNDS AND THEIR USES
EP 2968180 B1申请人: AMGEN INC优先权: 2013
EP
US
WO
4 件公开
Methods for treating heart failure by administering cardiac sarcomere activators
US 11986474 B1申请人: CYTOKINETICS INC优先权: 2023
US
WO
2 件公开
Combination therapy of cardiac myosin activator and sinus node if current inhibitor
US 10543215 B2申请人: AMGEN INC优先权: 2016
US
Solid state forms of Omecamtiv mecarbil and Omecamtiv mecarbil diHCl
US 11608318 B2申请人: ASSIA CHEM IND LTD优先权: 2019
US
THERAPEUTIC AND IMAGING AGENTS FOR TARGETING MYOCARDIAL TISSUE
US 20250049968 A1申请人: UNIV OKLAHOMA优先权: 2023
US
OMECAMTIV MECARBIL FOR USE IN TREATING HEART FAILURE BY ACTIVATING CARDIAC SARCOMERE
WO 2026050494 A1申请人: CYTOKINETICS INC优先权: 2024
WO

药物

Omecamtiv Mecarbil

概览

专利

SYNTHESIS OF OMECAMTIV MECARBIL